COVID-19 continues to cast a pall on strategic M&A activity in the diagnostics space with the key players monitoring events before making their moves. However, there are still a few smaller deals … [Read more...]
M&A Report
Danaher Closes $21.4 Billion GE Biopharma Acquisition
May 8, 2020
Although the COVID-19 pandemic has had a chilling effect on strategic acquisitions, M&A activity is still taking place, including the conclusion of the biggest deal in the diagnostics space in … [Read more...]
Diagnostic Deals
How Curative & KorvaLabs Created a Successful COVID-19 Testing Lab in Less than a Month
May 8, 2020
Say what you will about the current state and availability of COVID-19 diagnostic testing, the energetic, imaginative and speedy response by certain segments of the lab industry has been nothing short … [Read more...]
Diagnostic Deals
Labs, Universities and Even Computer Companies Target Point-of-Care COVID-19 Test Development
April 1, 2020
The imperative to create and provide tests capable of detecting the SARS-CoV-2 virus that causes COVID-19 coronavirus continues to fuel strategic deal making. SARS-CoV-2 point-of-care tests was the … [Read more...]
DIAGNOSTIC DEALS
Diagnostic Deals: Urgent Need for Coronavirus Diagnostics Fuels Strategic Collaboration
March 1, 2020
Not surprisingly, teaming up for development and commercialization of coronavirus (COVID-19) detection and vaccination products was a major theme of strategic alliance making during the period. … [Read more...]
DIAGNOSTIC DEALS
Diagnostic Deals: Lab Corp & Quest to Continue Targeting Small and Independent Labs for Acquisition
January 31, 2020
PAMA price cuts were supposed to drive consolidation in the lab market. The expectation was that price pressures would make it impossible for smaller labs to remain independent, rendering them juicy … [Read more...]
DEALS
Industry Buzz: The 10 Biggest DX Mergers of 2019
January 14, 2020
Conspicuous by its absence from the list is the proposed $1.2 billion Illumina takeover of Pacific Biosciences which suddenly seems to be in major trouble. Here are the 10-highest value M&A … [Read more...]
DIAGNOSTIC DEALS
Diagnostic Deals: Illumina/PacBio Merger Derails & Qiagen Takes Itself Out of Play
December 31, 2019
As 2019 came to a close, the biggest story in DX deal making was the pair of anticipated M&A deals that suddenly seem unlikely to happen. As a result, two major genetic testing companies will … [Read more...]
